by Sarah Buhr | Jan 17, 2017 | Business Enhancements, Startups, Venture Capital
It was cold and pouring outside as the Uber pulled up at 180 Sutter Street in downtown San Francisco. Inside, a man dressed all in black offered to take my jacket and umbrella as he ushered me through the clinical white lobby to a set of chairs, handing me a...
by Sarah Buhr | Jan 6, 2017 | Business Enhancements, Startups, Venture Capital
The early cancer screening startup Grail plans to raise more than $1 billion in Series B financing, possibly up to $1.8 billion. While the company doesn’t want to name investor names, only mentioning in a release the funding will come “primarily from...
by Sarah Buhr | Jan 5, 2017 | Business Enhancements, Venture Capital
Things are looking up for biotech and health device startups wanting to cash in on VC dollars or go public this year. According to Silicon Valley Bank’s latest report on healthcare investments and exits, a conservative 2016 has set 2017 up for a hearty...
by Sarah Buhr | Dec 13, 2016 | Business Enhancements
Lygos uses microbugs to convert low-cost sugar into specialty chemicals used in manufacturing and is now releasing a technique to make malic acid, an ingredient needed in the mass production of electronics. To do so, the company announced today it has raised $13...
by Sarah Buhr | Dec 13, 2016 | Business Enhancements
Clear Labs, a genomic data platform hoping to stop E-coli outbreaks in your favorite burrito chain before they start, has pulled in $13 million in Series B funding to build a next generation sequencing-based (NGS) microbiome test and grow the business....